Cover Image
市場調查報告書

合成生物學市場預測:各工具,技術,用途

Synthetic Biology Market by Tool, Technology - Global Forecast to 2018

出版商 MarketsandMarkets 商品編碼 320168
出版日期 內容資訊 英文 187 Pages
訂單完成後即時交付
價格
Back to Top
合成生物學市場預測:各工具,技術,用途 Synthetic Biology Market by Tool, Technology - Global Forecast to 2018
出版日期: 2014年11月19日 內容資訊: 英文 187 Pages
簡介

全球合成生物學市場預測從2013年到2018年將以24%的年複合成長率擴大,市值從2013年的19億2310萬美元達到2018年的56億3040萬美元。該市場就地區別來看預測將是北美最大,歐洲,亞洲,其他地區(ROW)次之。預測歐洲到2018年以金額為準將居首位。

本報告提供全球合成生物學市場趨勢的相關調查,提供您工具,技術,用途,及地區別市場分析,彙整主要的市場影響因素分析,競爭情形及主要企業簡介等資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 全球合成生物學市場從2013年到2018年預計將展現24%的年複合成長率
  • 合成生物學市場:地區·各用途
  • 各地區的概要
  • 生命週期分析:各地區

第5章 產業分析

  • 需求面方面
  • 供給方面

第6章 市場概要

  • 簡介
  • 市場動態
  • 波特的五力分析
  • 主要企業的競爭定位

第7章 合成生物學市場:各工具

  • 簡介
  • 異核酸(XNA)
  • 底盤有機體
  • oligo核甘酸
  • 酵素
  • cloning technology kits

第8章 合成生物學市場:各技術

  • 簡介
    • 可實現技術
    • 已實現技術

第9章 合成生物學市場:各用途

  • 簡介
    • 環境用途
    • 醫療用途
    • 產業用途

第10章 合成生物學市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲將為促進合成生物學市場的國際聯盟侈為優先
    • 預測合成生物學研究的大額資金將刺激歐洲市場的成長
    • 英國
    • 德國
    • 法國
    • 丹麥
    • 瑞士
    • 其他歐洲各國(ROE)
  • 亞洲
    • 中國
    • 日本
    • 其他的亞太地區
  • 其他地區(ROW)

第11章 競爭情形

  • 概要
  • 市場佔有率分析:合成生物學市場
  • 競爭情形 & 趨勢
  • 契約/合資企業/供給契約
  • 新產品的市場投入
  • 擴張
  • 收購
  • 其他
  • 成長策略的確證評估

第12章 企業簡介(概要,財務,產品 & 服務,策略,及近幾年的發展趨勢)

  • 簡介
  • AMYRIS, INC.
  • dupont
  • genscript USA, Inc.
  • intrexon corporation
  • integrated dna technologies (IDT), INC.
  • new england biolabs, Inc.
  • novozymes
  • royal dsm N.V.
  • SYNTHETIC GENOMICS, inc.
  • thermo fisher scientific, Inc.

第13章 附錄

圖表清單

目錄
Product Code: BT 2910

The synthetic biology market is rapidly evolving, with various technological advancements that have resulted in a paradigm shift within the market. This has resulted in advanced production of synthetic genes and chassis to develop synthetic organisms from scratch.

In 2013, the oligonucleotides segment accounted for the largest share of the global synthetic biology market, by tool, while enabling technologies accounted for the largest share of the synthetic biology market, by technology. The medical application segment accounted for a major share of the synthetic biology applications market in 2013.

North America accounted for the largest share of the global synthetic biology market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, Europe is expected to witness the highest growth rate, with emphasis on Germany, U.K., France, Denmark, Switzerland, and Rest of Europe. These countries are expected to serve as revenue pockets for synthetic biology manufacturers.

The global synthetic biology market witnesses high-competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various strategies (new product launches, acquisitions, and geographical expansions) to increase their market shares and to establish a strong foothold in the global market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the synthetic biology market. The report analyzes synthetic biology products by tools, technologies, applications, and region
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the synthetic biology market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various synthetic biology technologies across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the synthetic biology market
  • Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the synthetic biology market

Table of Contents

1 Introduction

  • 1.1 Objectives of the study
  • 1.2 market definition
  • 1.3 markets covered
  • 1.4 years considered for the study
  • 1.5 currency
  • 1.6 Package size
  • 1.7 limitations
  • 1.8 stakeholders

2 research methodology

  • 2.1.1 secondary and primary research methodology
    • 2.1.1.1 Secondary Research
  • 2.1.2 key data from secondary sources
    • 2.1.2.1 Primary Research
  • 2.1.3 key data from primary sources
  • 2.1.4 key Insights from primary sources
  • 2.1.5 market size estimation methodology
  • 2.1.6 MARKET FORECAST methodology
  • 2.1.7 MARKET DATA VALIDATION and DATA TRIANGULATION
  • 2.1.8 Assumptions

3 executive Summary

4 Premium insights

  • 4.1 Global synthetic biology market to witness a high CAGR of 24% from 2013 to 2018
  • 4.2 synthetic biology market, by region and application
  • 4.3 geographic snapshot
  • 4.4 LIFE CYCLE ANALYSIS, BY GEOGRAPHY

5 INDUSTRY SPEAKS

  • 5.1 Demand Side
  • 5.2 Supply Side

6 Market Overview

  • 6.1 introduction
  • 6.2 Market dynamics
    • 6.2.1 drivers
      • 6.2.1.1 Rising R&D expenditure of pharmaceutical and biotechnology companies
      • 6.2.1.2 Increasing demand for synthetic genes
      • 6.2.1.3 Rise in the global production of genetically modified crops
      • 6.2.1.4 Increase in funding
    • 6.2.2 RESTRAInt
      • 6.2.2.1 Ethical and societal issues
    • 6.2.3 challenge
      • 6.2.3.1 Standardization of biological parts
    • 6.2.4 opportunities
      • 6.2.4.1 Rising concerns on fuel consumption
      • 6.2.4.2 Increasing demand for protein therapeutics
  • 6.3 porter's five forces analysis
    • 6.3.1 threat of new Entrants
    • 6.3.2 bargaining power of Suppliers
    • 6.3.3 bargaining power of Buyers
    • 6.3.4 Segment rivalry
    • 6.3.5 Threat of substitutes
  • 6.4 Competitive positioning of key players
    • 6.4.1 INTRODUCTION
    • 6.4.2 key highlights

7 synthetic biology Market, By tool 4

  • 7.1 INTRODUCTION
  • 7.2 xeno-nucleic acids (XNAs)
  • 7.3 chassis organisms
  • 7.4 oligonucleotides
  • 7.5 enzymes
  • 7.6 cloning technology kits

8 SYnthetic biology Market, By TECHNOLOGY 5

  • 8.1 introduction
    • 8.1.1 ENABLING TECHNOLOGIES
      • 8.1.1.1 GENE SYNTHESIS
      • 8.1.1.2 BIOINFORMATICS
      • 8.1.1.3 GENOME ENGINEERING
      • 8.1.1.4 CLONING AND SEQUENCING
      • 8.1.1.5 SITE-DIRECTED MUTAGENESIS (SDM)
      • 8.1.1.6 MEASUREMENT AND MODELING
      • 8.1.1.7 MICROFLUIDICS
      • 8.1.1.8 NANOTECHNOLOGY
    • 8.1.2 ENABLed TECHNOLOGIES
      • 8.1.2.1 PATHWAY ENGINEERING
      • 8.1.2.2 NEXT-GENERATION SEQUENCING

9 SYnthetic biology Market, By application

  • 9.1 INTRODUCTION
    • 9.1.1 environmental applications
      • 9.1.1.1 Bioremediation
      • 9.1.1.2 Whole-cell Biosensors
    • 9.1.2 medical Applications
      • 9.1.2.1 Drug Discovery and Therapeutics
      • 9.1.2.2 Pharmaceuticals
      • 9.1.2.3 Artificial Tissue and Tissue Regeneration
    • 9.1.3 industrial applications
      • 9.1.3.1 Biofuel & Renewable Energy
      • 9.1.3.2 Industrial Enzymes
      • 9.1.3.3 Biomaterials & Green Chemicals

10 synthetic biology market, by Geography

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 U.S.
      • 10.2.1.1 Government Investments propelling the synthetic biology market in the U.S.
      • 10.2.1.2 Increase in number of synthetic biology companies and research institutes boosting U.S. market
    • 10.2.2 CANADA
      • 10.2.2.1 Synthetic biology-related conferences and workshops promoting research activities in Canada
  • 10.3 europe
    • 10.3.1 europe prioritizing international alliances to boost synthetic biology market
    • 10.3.2 heavy funding for synthetic biology research likely to stimulate market growth in europe
    • 10.3.3 U.K.
      • 10.3.3.1 Strong government support for synthetic biology in the U.K.
    • 10.3.4 Germany
      • 10.3.4.1 Strong investments driving the synthetic biology market in Germany
    • 10.3.5 France
      • 10.3.5.1 Rising awareness to boost synthetic biology market growth in France
    • 10.3.6 Denmark
    • 10.3.7 Switzerland
      • 10.3.7.1 Switzerland synthetic biology market buoyed by investments
    • 10.3.8 Rest of Europe (RoE)
  • 10.4 asia
    • 10.4.1 China
      • 10.4.1.1 Collaborations related to synthetic biology likely to spur innovation and research in synthetic biology in China
      • 10.4.1.2 Increasing number of conferences to boost awareness of synthetic biology
    • 10.4.2 Japan
      • 10.4.2.1 Established biotechnology industry makes Japan the leading Asian country in synthetic biology
    • 10.4.3 Rest of asia (RoA)
      • 10.4.3.1 Government investments and conferences stimulating the demand for synthetic biology in the RoA
  • 10.5 REST OF THE WORLD (ROW)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 Market share analysis, synthetic biology market
    • 11.2.1 INTRODUCTION
      • 11.2.1.1 Thermo Fisher Scientific, Inc. (U.S.)
      • 11.2.1.2 Royal DSM N.V. (NETHERLANDS)
      • 11.2.1.3 DuPont (U.S.)
  • 11.3 competitive situation and trends
  • 11.4 agreements, partnerships, collaborations, and joint ventures
  • 11.5 NEW PRODUCT LAUNCHES
  • 11.6 ExpansionS
  • 11.7 ACQUISITIONS
  • 11.8 OTHERs
  • 11.9 Emperical Assessment OF Growth Strategies
    • 11.9.1 Route to Strategic Growth: Organic and Inorganic Growth Strategies
    • 11.9.2 ORGANIC GROWTH STRATEGIES
    • 11.9.3 INORGANIC GROWTH STRATEGIES

12 Company profiles

(Overview, Financials, Products & Services, Strategy, & Developments)*

  • 12.1 introduction
  • 12.2 AMYRIS, INC.
  • 12.3 dupont
  • 12.4 genscript USA, Inc.
  • 12.5 intrexon corporation
  • 12.6 integrated dna technologies (IDT), INC.
  • 12.7 new england biolabs, Inc.
  • 12.8 novozymes
  • 12.9 royal dsm N.V.
  • 12.10 SYNTHETIC GENOMICS, inc.
  • 12.11 thermo fisher scientific, Inc.

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 Related reports

LIST OF TABLES

  • TABLE 1 increasing demand for synthetic genes PROPELLING market GROWTH
  • TABLE 2 ETHICAL AND SOCIETAL ISSUES SUCH AS BIOSAFETY AND BIOSECURITY RESTRAINT MARKET growth
  • TABLE 3 Standardization of biological parts is a major challenge FACED by SYNTHETIC BIOLOGY market players
  • TABLE 4 rising concerns about fuel consumption is a major GROWTH OPPORTUNITy IN THE GLOBAL SYNTHETIC BIOLOGY MARKET
  • TABLE 5 synthetic biology MARKET SIZE, BY segment, 2012-2018 ($MILLION)
  • TABLE 6 synthetic biology MARKET SIZE, BY tool, 2012-2018 ($MILLION)
  • TABLE 7 synthetic biology tools MARKET SIZE, BY REGION, 2012-2018 ($MILLION)
  • TABLE 8 synthetic biology MARKET SIZE for xeno-nucleic acids, BY REGION, 2012-2018 ($MILLION)
  • TABLE 9 synthetic biology MARKET SIZE for chassis organisms, BY REGION, 2012-2018 ($MILLION)
  • TABLE 10 synthetic biology MARKET SIZE for oligonucleotides, BY REGION, 2012-2018 ($MILLION)
  • TABLE 11 synthetic biology MARKET SIZE for enzymes, BY REGION, 2012-2018 ($MILLION)
  • TABLE 12 synthetic biology MARKET SIZE for cloning technology kits, BY REGION, 2012-2018 ($MILLION)
  • TABLE 13 synthetic biology technologies market size, by region, 2012-2018 ($MILLION)
  • TABLE 14 synthetic biology market size, by technology, 2012-2018 ($million)
  • TABLE 15 synthetic biology market size for enabling technologies, by region, 2012-2018
  • TABLE 16 synthetic biology market size for enabling technologies, by segment, 2012-2018
  • TABLE 17 synthetic biology market size for gene synthesis, by region, 2012-2018 ($million)
  • TABLE 18 synthetic biology market for bioinformatics, by region, 2012-2018 ($million)
  • TABLE 19 synthetic biology market size for genome engineering, by region, 2012-2018 ($million)
  • TABLE 20 synthetic biology market size for cloning and sequencing, by region, 2012-2018 ($million)
  • TABLE 21 synthetic biology market size for site-directed mutagenesis, by region, 2012-2018 ($million)
  • TABLE 22 synthetic biology market size for measurement and modeling, by region, 2012-2018 ($million)
  • TABLE 23 synthetic biology market size for microfluidics, by region, 2012-2018 ($million)
  • TABLE 24 synthetic biology market size for nanotechnology, by region, 2012-2018 ($million)
  • TABLE 25 synthetic biology market size for enabled technologies, by region, 2012-2018 ($million)
  • TABLE 26 synthetic biology market size for enabled technologies, by segment, 2012-2018 ($million)
  • TABLE 27 synthetic biology market size for pathway engineering, by region, 2012-2018 ($million)
  • TABLE 28 synthetic biology market size for next-generation sequencing, by region, 2012-2018 ($million)
  • TABLE 29 synthetic biology applications market size, by region, 2012-2018 ($mILLION)
  • TABLE 30 synthetic biology market size, by application, 2012-2018 ($million)
  • TABLE 31 synthetic biology market size for Environmental applications, by region, 2012-2018
  • TABLE 32 synthetic biology market size for environmental applications, BY SEGMENT, 2012-2018 ($MILLION)
  • TABLE 33 synthetic biology market size for bioremediation, by region, 2012-2018 ($million)
  • TABLE 34 synthetic biology market size for whole-cell biosensors, by region, 2012-2018 ($million)
  • TABLE 35 synthetic biology market size for medical applications, by region, 2012-2018 ($million)
  • TABLE 36 synthetic biology market size for Medical applications, by segment, 2012-2018 ($million)
  • TABLE 37 synthetic biology market size for drug discovery and therapeutics, by region, 2012-2018 ($million)
  • TABLE 38 synthetic biology market size for pharmaceuticals, by region, 2012-2018 ($million)
  • TABLE 39 synthetic biology market size for artificial tissue and tissue regeneration, by region, 2012-2018 ($million)
  • TABLE 40 synthetic biology market size for industrial applications, by region, 2012-2018 ($million)
  • TABLE 41 synthetic biology market size for industrial applications, by segment, 2012-2018 ($million)
  • TABLE 42 synthetic biology market size for biofuel and renewable energy, by region, 2012-2018 ($million)
  • TABLE 43 synthetic biology market size for industrial enzymes, by region, 2012-2014 ($million)
  • TABLE 44 synthetic biology market size for biomaterials and green chemicals, by region, 2012-2018 ($million)
  • TABLE 45 synthetic biology MARKET SIZE, by region, 2012-2018 ($MILLION)
  • TABLE 46 north america: synthetic biology market size, by COUNTRY, 2012-2018 ($million)
  • TABLE 47 north america: synthetic biology market size, by segment, 2012-2018 ($million)
  • TABLE 48 north america: synthetic biology tools market size, 2012-2018 ($million)
  • TABLE 49 north america: synthetic biology technologies market size, 2012-2018 ($million)
  • TABLE 50 north america: synthetic biology enabling technologies market size, 2012-2018 ($million)
  • TABLE 51 north america: synthetic biology enabled technologies market size, 2012-2018 ($million)
  • TABLE 52 north america: synthetic biology market size, by application, 2012-2018 ($million)
  • TABLE 53 U.S.: synthetic biology market size, by segment, 2012-2018 ($million)
  • TABLE 54 U.S.: synthetic biology market size, by application, 2012-2018 ($million)
  • TABLE 55 canada: synthetic biology market size, by segment, 2012-2018 ($million)
  • TABLE 56 canada: synthetic biology market size, by application, 2012-2018 ($million)
  • TABLE 57 europe: synthetic biology market size, by country, 2012-2018 ($million)
  • TABLE 58 europe: synthetic biology market size, by segment, 2012-2018 ($million)
  • TABLE 59 europe: synthetic biology tools market size, 2012-2018 ($million)
  • TABLE 60 europe: synthetic biology technologies market size, 2012-2018 ($million)
  • TABLE 61 europe: synthetic biology enabling technologies market size, 2012-2018 ($million)
  • TABLE 62 europe: synthetic biology enabled technologies market size, 2012-2018 ($million)
  • TABLE 63 europe: synthetic biology market size, by application, 2012-2018 ($million)
  • TABLE 64 U.K.: synthetic biology market size, by segment, 2012-2018 ($million)
  • TABLE 65 U.K.: synthetic biology market size, by application, 2012-2018 ($million)
  • TABLE 66 germany: synthetic biology market size, by segment, 2012-2018 ($million)
  • TABLE 67 germany: synthetic biology market size, by application, 2012-2018 ($million)
  • TABLE 68 france: synthetic biology market size, by segment, 2012-2018 ($million)
  • TABLE 69 france: synthetic biology market size, by applicatio, 2012-2018 ($million)
  • TABLE 70 denmark: synthetic biology market size, by segment, 2012-2018 ($million)
  • TABLE 71 denmark: synthetic biology market size, by application, 2012-2018 ($million)
  • TABLE 72 switzerland: synthetic biology market size, by segment, 2012-2018 ($million)
  • TABLE 73 switzerland: synthetic biology market size, by application, 2012-2018 ($million)
  • TABLE 74 roe: synthetic biology market size, by segment, 2012-2018 ($million)
  • TABLE 75 roe: synthetic biology market size, by application, 2012-2018 ($million)
  • TABLE 76 asia: synthetic biology market size, by country, 2012-2018 ($million)
  • TABLE 77 asia: synthetic biology market size, by segment, 2012-2018 ($million)
  • TABLE 78 asia: synthetic biology tools market size, 2012-2018 ($million)
  • TABLE 79 asia: synthetic biology technologies market size, 2012-2018 ($million)
  • TABLE 80 asia: synthetic biology enabling technologies market size, 2012-2018 ($million)
  • TABLE 81 asia: synthetic biology enabled technologies market size, 2012-2018 ($million)
  • TABLE 82 asia: synthetic biology market size, by application, 2012-2018 ($million)
  • TABLE 83 china: synthetic biology market size, by segment, 2012-2018 ($million)
  • TABLE 84 china: synthetic biology market size, by application, 2012-2018 ($million)
  • TABLE 85 japan: synthetic biology market size, by segment, 2012-2018 ($million)
  • TABLE 86 japan: synthetic biology market size, by application, 2012-2018 ($million)
  • TABLE 87 roa: synthetic biology market size, by segment, 2012-2018 ($million)
  • TABLE 88 roa: synthetic biology market size, by application, 2012-2018 ($million)
  • TABLE 89 row: synthetic biology market size, by segment, 2012-2018 ($million)
  • TABLE 90 row: synthetic biology tools market size, 2012-2018 ($million)
  • TABLE 91 RoW: synthetic biology technologies market size, 2012-2018 ($million)
  • TABLE 92 row: synthetic biology enabling technologies market size, 2012-2018 ($million)
  • TABLE 93 row: synthetic biology enabled technologies market size, 2012-2018 ($million)
  • TABLE 94 row: synthetic biology market size, by application, 2012-2018 ($million)
  • TABLE 95 agreements, partnerships, collaborations, and joint ventures, 2011-2014
  • TABLE 96 NEW PRODUCT LAUNCHES, 2011-2013
  • TABLE 97 expansions, 2011-2014
  • TABLE 98 acquisitions, 2011-2014
  • TABLE 99 others, 2011-2014

LIST OF FIGURES

  • FIGURE 1 synthetic biology market segmentation
  • FIGURE 2 global synthetic biology market: research methodology steps
  • FIGURE 3 Sampling Frame: Primary Research
  • FIGURE 4 BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY type, DESIGNATION, and REGION
  • FIGURE 5 market size estimation methodology: Bottom-up approach
  • FIGURE 6 market size estimation methodology: top-down approach
  • FIGURE 7 MARKET FORECAST methodology
  • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • FIGURE 9 global synthetic biology market snapshot, by segment, 2013-2018
  • FIGURE 10 Enabling technologies market segment to witness highest cagr OF 24.8% from 2013 to 2018
  • FIGURE 11 global synthetic biology market, by application 2013
  • FIGURE 12 global synthetic biology market, by geography, 2013
  • FIGURE 13 synthetic biology: market overview
  • FIGURE 14 north america to dominate the synthetic biology Market in 2013
  • FIGURE 15 europe to witness the highest CAGR During the forecast period
  • FIGURE 16 global synthetic biology market to witness significant GROWTH IN the COMING YEARS
  • FIGURE 17 INCREASING DEMAND FOR SYNTHETIC GENEs TO SPUR MARKET growth
  • FIGURE 18 porter's five forces analysis: synthetic biology market
  • FIGURE 19 competitive positioning, by key player (2014)
  • FIGURE 20 technologies segment to grow at a higher pace in forecast period
  • FIGURE 21 europe to be the fastest-growing synthetic biology market, by tool from 2013 to 2018
  • FIGURE 22 oligonucleotides segment commanded largest market share in 2013
  • FIGURE 23 synthetic biology technologies market, 2013 vs. 2018
  • FIGURE 24 synthetic biology technology market in europe to grow at highest cagr in forecast period
  • FIGURE 25 Enabling technologies segment to grow at higher cagr of 24.8%
  • FIGURE 26 bioinformatics segment to grow at highest cagr of 26.2% in forecast period
  • FIGURE 27 next-generation sequencing to grow at higher cagr of 24.9%
  • FIGURE 28 synthetic biology applications market, 2013 Vs. 2018
  • FIGURE 29 medical to grow at the highest CAGR in the global synthetic biology applications market
  • FIGURE 30 bioremediation to grow at the highest cagr of 23%
  • FIGURE 31 drug discovery and therapeutics segment to grow at the highest cagr
  • FIGURE 32 biofuel and renewable energy segment accounted for A share of 53% of the synthetic biology market in 2013
  • FIGURE 33 synthetic biology market in EUROPE to grow at highest CAGR (25.4%) from 2013 to 2018
  • FIGURE 34 north america accounted for largest share of 43% of synthetic biology market (2013)
  • FIGURE 35 U.K. to be the fastest-growing market for synthetic biology in EUROPE
  • FIGURE 36 COMPANIES ADOPTED AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURES AS KEY GROWTH STRATEGY in LAST THREE YEARS
  • FIGURE 37 Market share analysis, by key player, 2013
  • FIGURE 38 KEY GROWTH STRATEGIES OF THE GLOBAL SYNTHETIC BIOLOGY MARKET, 2011-2014
  • FIGURE 39 BATTLE FOR MARKET SHARE: aGREEMENTS, partnerships, Collaboration, and Joint Ventures WAS THE KEY STRATEGY
  • FIGURE 40 Organic and inorganic growth strategies
  • FIGURE 41 ORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2011-2014)
  • FIGURE 42 INORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2011-2014)
  • FIGURE 43 Geographical revenue mix of top 4 players
  • FIGURE 44 DUPONT: company snapshot
  • FIGURE 45 GENSCRIPT USA Inc.: company snapshot
  • FIGURE 46 intrexon corpoRAtion : company snapshot
  • FIGURE 47 integrated dna technologies (IDT): company snapshot
  • FIGURE 48 new england biolabs, Inc.: company snapshot
  • FIGURE 49 company snapshot
  • FIGURE 50 synthetic genomics, Inc.: company snapshot
  • FIGURE 51 company snapshot
Back to Top